Latest Insider Transactions at Akari Therapeutics PLC (AKTX)
This section provides a real-time view of insider transactions for Akari Therapeutics PLC (AKTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Akari Therapeutics Plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Akari Therapeutics Plc's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 27
2024
|
Abizer Gaslightwala |
BUY
Grant, award, or other acquisition
|
Direct |
40,000,000
+36.36%
|
-
|
Dec 26
2024
|
Abizer Gaslightwala |
BUY
Grant, award, or other acquisition
|
Direct |
30,000,000
+50.0%
|
-
|
Dec 23
2024
|
James R Neal |
BUY
Grant, award, or other acquisition
|
Direct |
2,000,000
+7.63%
|
-
|
Dec 02
2024
|
Raymond Prudo Chlebosz |
BUY
Grant, award, or other acquisition
|
Direct |
419,286,000
+9.32%
|
-
|
Jun 30
2024
|
Samir Rashmikant Patel |
BUY
Grant, award, or other acquisition
|
Direct |
91,396,000
+50.0%
|
-
|
May 31
2024
|
Raymond Prudo Chlebosz |
BUY
Grant, award, or other acquisition
|
Direct |
0
|
-
|
May 31
2024
|
Samir Rashmikant Patel |
BUY
Grant, award, or other acquisition
|
Indirect |
0
|
-
|
May 01
2024
|
Wendy F Dicicco Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
158,473,915
+50.0%
|
-
|
Apr 26
2024
|
Rachelle Suzanne Jacques Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
479,569,892
+32.02%
|
-
|